Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.16.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.1.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.49ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.49ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.49ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.49NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBL.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBL.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FR.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FR.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FR.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.18.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.18.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.18.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.18.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.23.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.23.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.23.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.23.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.21.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used